We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Alliance for Developing Hepatotoxic Assay

By Biotechdaily staff writers
Posted on 05 Oct 2006
Bionas GmbH (Rostock, Germany) and Primacyt (Schwerin, Germany), are cooperating on the development of a cell-based assay using primary human hepatocytes for predicting hepatotoxic effects in response to test compounds. More...


Primary human hepatocytes, provided by Primacyt, are cultivated directly on collagen-coated Bionas metabolic chips SC1000 with Primacyt's chemically defined media. The chips are then placed into the Bionas 2500 analyzing system to evaluate the effects of test compounds. After a recovery period, the hepatocytes can be re-used for further experiments in the Bionas 2500 analyzing system.

Predicting liver toxicity is a major concern, and non-immortalized primary human hepatocytes can be used as biosensors for the analysis of drugs, food additives, and chemicals. A cell-based assay based on the Bionas 2500 analyzing system and primary hepatocytes may aid compound selection in the drug discovery process and may reduce both the number of animal studies and preclinical development time.

Bionas specializes in analyzing systems and services for in-vitro profiling of the metabolic activity of cells to understand cellular function. The Bionas 2500 analyzing system measures extracellular acidification, oxygen consumption, and cell adhesion in a label-free and non-invasive manner, and can be applied to various cell types including primary cells. The readout is carried out continuously and can be watched online. Main applications include drug profiling, lead optimization, pharmaco kinetics, and early toxicology programs.

Primacyt cell culture technology offers a validated, serum-free, long-term human hepatocyte culture system. Hepac2 serves as a biosensor for the toxicologic analysis of drugs, food additives, and chemicals and their impact on hepatocellular metabolism and functions.



Related Links:
Bionas
Primacyt

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.